Skip to main content
Forgetfulness, it turns out, is all in the head. Scientists have shown that fading memory and clouding judgment, the type that comes with advancing age, show up as lost and altered connections between neurons in the brain. But new experiments suggest an existing drug, known as riluzole and alread...

It’s the most basic of ways to find out what something does, whether it’s an unmarked circuit breaker or an unidentified gene — flip its switch and see what happens. New remote-control technology may offer biologists a powerful way to do this with cells and genes. A team at Rockefeller Univers...

Stem cells in early embryos have unlimited potential; they can become any type of cell, and researchers hope to one day harness this rejuvenating power to heal disease and injury. To do so, they must, among other things, figure out how to reliably arrest stem cells in a Peter Pan-like state of in...

A collaborative research team at The Rockefeller University Center for Clinical and Translational Science and Clinical Directors Network has received a $2.8 million contract award from a nonprofit organization to study a home-based intervention to prevent recurrence of a community-acquired drug-r...

Whether stubbing a toe or stroking a cat, the sensation of touch starts out as a mechanical force that is then transformed into an electrical signal conveying pain or other sensations. Tiny channels in neurons act as translators by helping to formulate that signal to the brain. However, scientist...

A group of chief executive officers from leading biotechnology companies has presented Marc Tessier-Lavigne, Rockefeller’s president, with a Lifetime Achievement Award in recognition of his leadership in the bioscience community. The award was announced at a Boston Biotech Conference of executive...

Marc Tessier-Lavigne, president of The Rockefeller University, today announced two leadership pledges of $75 million each from the Stavros Niarchos Foundation and David Rockefeller to launch a major extension of the University’s campus on the East River. Dr. Tessier-Lavigne said, “These pledg...

Tri-I TDI makes modeling software available. The Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) has signed an agreement to provide access to Schrödinger’s materials science, biologics and small‑molecule drug discovery suites to researchers within Tri-I TDI’s member insti...

by WYNNE PARRY Joseph Gleeson, a neurogeneticist who uses genetic sequencing to identify the causes of pediatric brain disease across its spectrum, including epilepsy, autism, intellectual disability and structural disorders, has joined Rockefeller as a professor and established the Laboratory of...

by WYNNE PARRY Hironori Funabiki, head of the Laboratory of Chromosome and Cell Biology, was promoted to professor and granted tenure by the university’s Board of Trustees at its June meeting. Dr. Funabiki studies mitosis, the primary type of cell division that underlies all growth, maintenance a...